Robin Zoň

Phase II Trial of Cisplatin, Gemcitabine, and Bevacizumab As First-Line Therapy for Metastatic Urothelial Carcinoma: Hoosier Oncology Group GU 04-75

Noah M. Hahn, Walter M. Stadler, Robin Zoň et al. · Journal of Clinical Oncology · 2011 · 189 citations · Full text

American Society of Clinical Oncology Provisional Clinical Opinion: Chronic Hepatitis B Virus Infection Screening in Patients Receiving Cytotoxic Chemotherapy for Treatment of Malignant Diseases

Andrew Artz, Mark R. Somerfield, Jordan J. Feld et al. · Journal of Clinical Oncology · 2010 · 159 citations

A phase 2 trial of consolidation pembrolizumab following concurrent chemoradiation for patients with unresectable stage III non–small cell lung cancer: Hoosier Cancer Research Network LUN 14‐179

Greg Andrew Durm, Salma K. Jabbour, Sandra K. Althouse et al. · Cancer · 2020 · 158 citations · Full text

The National Cancer Institute–American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and Recommendations

Andrea Denicoff, Worta McCaskill‐Stevens, Stephen S. Grubbs et al. · Journal of Oncology Practice · 2013 · 142 citations · Full text

A randomized phase III trial of paclitaxel with or without bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer: Eastern cooperative oncology group trial E2100

Robin Zoň, K. Miller, M. Wang et al. · European Journal of Cancer Supplements · 2006 · 135 citations

First-line Therapy, Metastatic Breast Cancer, Breast Oncology +7